A reduction in Medicare Part B premiums remains in play. Here's where things stand

By CNBC
| May 01, 2022

CMS continues to evaluate the Part B premium, given changes that have occurred since the monthly amount was set last year.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...